Emicizumab‑Kxwh Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL
Reference Brands: Hemlibra (USA/EU)
Category:
Plasma Products
Emicizumab-kxwh is a humanized bispecific monoclonal antibody (IgG4) that simultaneously binds activated factor IX (FIXa) and factor X (FX), thereby functioning as a factor VIII cofactor‐mimetic in patients with congenital haemophilia A.
It is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with haemophilia A, with or without factor VIII inhibitors. It offers subcutaneous administration (once weekly, biweekly or every 4 weeks) compared to more frequent intravenous factor VIII infusions.
Emicizumab‑kxwh is available in Injection
and strengths such as 30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Emicizumab‑kxwh is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Emicizumab‑kxwh can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing